-
2025
-
04
Released interim results of IMD10 clinical trial for pancreatic cancer
-
02
Designated as a BDD (Breakthrough Device Designation)
-
-
2024
-
11
Designated as GMP (Good Manufacturing Practice)
-
11
Awarded the IR52 Jang Young-Shil Award (Technology Innovation Award)
-
11
Award of Commendation from the Minister of Trade, Industry and Energy
-
05
Designated as NET (New Excellent Technology)
-
04
Award of Commendation from the Minister of Science and ICT
-
-
2023
-
12
Designated as an excellent corporate research institute
-
11
IMD20 Medical Device clinical trial approval
-
09
Signed MOU with Samsung Medison
-
08
IMP101 Medical Device clinical trial approval
-
08
Signed MOU with Viol
-
08
IMP301 Approval of Clinical Trials for Pharmaceutical Product
(Investigational New Drug ; IND) -
07
Selected for the Industrial Technology innovation Project-materials,
components, and Technology development-($17 Million) -
07
Listed on the KONEX market
-
-
2022
-
10
Received the 7th LeeMinHwa’s Medical Entrepreneurship Award (CEO, Hakjoing Lee)
-
08
IMD10 Medical Device clinical trial approval
-
07
ISO:9001 approval
-
06
Signed MOU with Bundang Convergence Technology Education Center
(Korea Polytechnics) -
03
MAINBiz approval
-
02
Selected for Scale-up TIPS Project
-
-
2021
-
12
Series C Funding
-
12
Signed MOU with HysensBio
-
09
Signed MOU with ToolGen
-
06
Participation and Sponsorship at International Symposium for Therapeutic Ultrasound (ISTU 2021)
-
04
Medical device GMP approval review
-
04
Selected for medical device suitability support project
-
02
Selected IPO underwriter (DB Financial Investment)
-
-
2020
-
12
Signed MOU with Dongkook Life Science
-
11
Series B-2(Bridge) Funding
-
08
Selected for the full cycle governmental project ($ 5 million)
-
06
Signed MOU with Huons
-
05
Selected for recruitment support project for young researchers
-
-
2019
-
10
Contract out ultrasound device design to Cheongju University
-
09
Participation and Sponsorship at Korean Society for Therapeutic Ultrasound (KSTU 2019)
-
05
Office relocation and expansion
-
04
Appointed CTO
-
02
Appointed CFO
-
-
2018
-
12
Series B Funding
-
09
Selected for high-tech medical technology development project by the Ministry of Health and Welfare, 4th year agreement
-
-
2017
-
11
Selected for high-tech medical technology development project by the Ministry of Health and Welfare, 3rd year agreement
-
10
Selected for Gyeonggi Province technology development project
-
09
Selected for TIPS Program’s Global Advancement Support by Small and Medium Business Administration(SMBA)
-
05
Selected for R&D planning support project by SMBA
-
2016
-
12
Series A Funding
-
11
Selected for high-tech medical technology development project by the Ministry of Health and Welfare, 2nd year agreement
-
10
Established Company’s R&D center
-
05
Selected as a planning task force for the Medi-Bio Cluster by Seongnam District’s Industry Promotion Agency
-
-
2015
-
11
Selected for high-tech medical technology development project by the Ministry of Health and Welfare, 1st year agreement
-
10
Selected for TIPS project by Small and Medium Business Administration
-
-
2010
-
10
Registered as a Venture Company by the Korean Government
-
04
Established IMGT
-